Functional inactivation of HIF-1α shifted the dose dependency of growth inhibition towards lower drug concentrations (Figure 1A and Figure S1), suggesting that HIF-1α is capable to reduce chemotherapy susceptibility of gastric cancer cells under normoxic conditions. This evidence concerns the gene HIF1A and gastric cancer.